Evaluation of Vancomycin Prediction Methods Based on Estimated Creatinine Clearance or Trough Levels

M Haeseker, S Croes, C Neef, C Bruggeman, L Stolk, Annelies Verbon

Research output: Contribution to journalArticleAcademicpeer-review

18 Citations (Scopus)


Background:The aim of this study was to investigate whether vancomycin clearance (CLva) can be adequately predicted with CLva prediction methods. Additionally, other covariates influencing the CLva were investigated and predictivity of monitoring of only trough levels to 24-hour area under the curve (AUC(24)) was evaluated.Methods:Routine vancomycin plasma levels were measured with a fluorescence polarization immunoassay. Pharmacokinetic (PK) parameters of individual patients, that is, CLva and volume of distribution, were determined with maximum a posteriori Bayesian estimation. CLva was calculated with the 3 prediction methods, which are solely based on creatinine clearance (CLcr) estimated with Cockcroft and Gault formula and was compared with the calculated CLva with maximum a posteriori Bayesian estimation. Prediction errors were calculated. Correlations between CLva and CLcr, creatinine, age, weight, sex, and neutropenia were made. Furthermore, correlations between trough levels and AUC(24) were evaluated.Results:A total of 171 patients were included. Prediction errors and absolute prediction errors of the 3 methods ranged from 28% to 80% and 39% to 83%, respectively. In the multivariate analysis, CLva was significantly associated with CLcr, creatinine, age, weight, sex, and neutropenia. Linear correlation between AUC(24) and trough levels was R-2 0.38.Conclusions:Large prediction errors make the CLva algorithms based on estimated plasma CLcr unsuitable for use in patient care. Additionally, other factors, which are not accounted for in the current algorithms, influence the CLva individually. Owing to low association of AUC(24) and trough levels, the AUC(24) cannot be predicted with through levels. For a reliable AUC(24) guided vancomycin dosing, therapeutic drug monitoring is necessary.
Original languageUndefined/Unknown
Pages (from-to)120-126
Number of pages7
JournalTherapeutic Drug Monitoring
Issue number1
Publication statusPublished - 2016

Research programs

  • EMC MM-04-28-04

Cite this